Effectiveness of acupuncture for fatigue in patients with relapsing-remitting multiple sclerosis : a randomized controlled trial
BACKGROUND: Fatigue is experienced by more than 65% of individuals with multiple sclerosis (MS). Some studies have supported the effectiveness of acupuncture in improving the symptoms of MS.
OBJECTIVE: The present research was intended to investigate the effectiveness of acupuncture plus amantadine compared with amantadine alone on fatigue in patients with relapsing-remitting MS (RRMS) in the remission stage of the disease.
METHODS: In this randomized controlled trial, 60 participants with RRMS suffering from fatigue were recruited and randomized equally to acupuncture (n = 30) and control (n = 30) groups. The acupuncture group received treatment 2 to 3 times per week for 10 sessions over 4 weeks. Both the acupuncture and control groups received amantadine 100 mg daily and routine treatment with immuno-modulators. The primary outcome was the fatigue severity scale (FSS) score, which was evaluated at baseline, and after 2 and 4 weeks. The secondary outcome was the Multiple Sclerosis Quality of Life 54 (MSQOL-54) questionnaire score, measured at baseline and the end of the 4-week treatment period.
RESULTS: The severity of fatigue was reduced in both groups. However, after 4 weeks of treatment, the reduction of fatigue in the acupuncture group was more significant than in the control group (P < 0.01, mean difference (MD) = -1.14, 95% confidence interval (CI): -1.83 to -0.45). Quality of life, including mental and physical status, was significantly improved in the acupuncture group compared with the control group (P < 0.05, MD = 9.09, 95% CI: 0.46 to 17.73). No adverse events occurred in any of the participants.
CONCLUSIONS: Acupuncture combined with amantadine and routine care compared with amantadine and routine care alone appears to be an effective short-term treatment for reducing fatigue and enhancing quality of life, including physical function and mental status, in patients with RRMS.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Acupuncture in medicine : journal of the British Medical Acupuncture Society - 41(2023), 4 vom: 16. Aug., Seite 199-205 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Khodaie, Faezeh [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acupuncture |
---|
Anmerkungen: |
Date Completed 12.07.2023 Date Revised 18.07.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1177/09645284221150824 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352327715 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352327715 | ||
003 | DE-627 | ||
005 | 20231226053451.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/09645284221150824 |2 doi | |
028 | 5 | 2 | |a pubmed24n1174.xml |
035 | |a (DE-627)NLM352327715 | ||
035 | |a (NLM)36722418 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Khodaie, Faezeh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effectiveness of acupuncture for fatigue in patients with relapsing-remitting multiple sclerosis |b a randomized controlled trial |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.07.2023 | ||
500 | |a Date Revised 18.07.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Fatigue is experienced by more than 65% of individuals with multiple sclerosis (MS). Some studies have supported the effectiveness of acupuncture in improving the symptoms of MS | ||
520 | |a OBJECTIVE: The present research was intended to investigate the effectiveness of acupuncture plus amantadine compared with amantadine alone on fatigue in patients with relapsing-remitting MS (RRMS) in the remission stage of the disease | ||
520 | |a METHODS: In this randomized controlled trial, 60 participants with RRMS suffering from fatigue were recruited and randomized equally to acupuncture (n = 30) and control (n = 30) groups. The acupuncture group received treatment 2 to 3 times per week for 10 sessions over 4 weeks. Both the acupuncture and control groups received amantadine 100 mg daily and routine treatment with immuno-modulators. The primary outcome was the fatigue severity scale (FSS) score, which was evaluated at baseline, and after 2 and 4 weeks. The secondary outcome was the Multiple Sclerosis Quality of Life 54 (MSQOL-54) questionnaire score, measured at baseline and the end of the 4-week treatment period | ||
520 | |a RESULTS: The severity of fatigue was reduced in both groups. However, after 4 weeks of treatment, the reduction of fatigue in the acupuncture group was more significant than in the control group (P < 0.01, mean difference (MD) = -1.14, 95% confidence interval (CI): -1.83 to -0.45). Quality of life, including mental and physical status, was significantly improved in the acupuncture group compared with the control group (P < 0.05, MD = 9.09, 95% CI: 0.46 to 17.73). No adverse events occurred in any of the participants | ||
520 | |a CONCLUSIONS: Acupuncture combined with amantadine and routine care compared with amantadine and routine care alone appears to be an effective short-term treatment for reducing fatigue and enhancing quality of life, including physical function and mental status, in patients with RRMS | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Journal Article | |
650 | 4 | |a acupuncture | |
650 | 4 | |a fatigue | |
650 | 4 | |a multiple sclerosis | |
650 | 4 | |a quality of life | |
650 | 7 | |a Amantadine |2 NLM | |
650 | 7 | |a BF4C9Z1J53 |2 NLM | |
700 | 1 | |a Naser Moghadasi, Abdorreza |e verfasserin |4 aut | |
700 | 1 | |a Kazemi, Amir Hooman |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Baixiao |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Acupuncture in medicine : journal of the British Medical Acupuncture Society |d 1997 |g 41(2023), 4 vom: 16. Aug., Seite 199-205 |w (DE-627)NLM092565751 |x 1759-9873 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2023 |g number:4 |g day:16 |g month:08 |g pages:199-205 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/09645284221150824 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2023 |e 4 |b 16 |c 08 |h 199-205 |